Skip to main content
Premium Trial:

Request an Annual Quote

Fulgent Genetics: Reggie Groves

Fulgent Genetics has added Reggie Groves to its board of directors, effective Jan. 3, 2023. Groves previously served in executive positions at Stimwave, REVA Medical, and Medtronic. She also has expertise in profit and loss responsibility for a publicly traded company, Fulgent said. Groves currently serves on the boards of Advanced NanoTherapies and AtriCure, a publicly traded company. She holds a BS in pharmacy from the University of Florida and an MBA from Harvard Graduate School of Business Administration.

The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.